The contribution of de novo and ultra-rare genetic variants in severe and moderate intellectual disability (ID) has been extensively studied whereas the genetic architecture of mild ID has been less well characterized. To elucidate the genetic background of milder ID we studied a regional cohort of 442 ID patients enriched for mild ID (>50%) from a population isolate of Finland. We analyzed rare variants using exome sequencing and CNV genotyping and common variants using common variant polygenic risk scores. As controls we used a Finnish collection of exome sequenced (n=11311) and GWAS chip genotyped (n=11699) individuals. We show that rare damaging variants in genes known to be associated with cognitive defects are observed more often in severe (27%) than in mild ID (13%) patients (p-value: 7.0e-4). We further observed a significant enrichment of protein truncating variants in loss-of-function intolerant genes, as well as damaging missense variants in genes not yet associated with cognitive defects (OR: 2.1, pvalue: 3e-8). For the first time to our knowledge, we show that a common variant polygenic load significantly contributes to all severity forms of ID. The heritability explained was the highest for educational attainment (EDU) in mild ID explaining 2.2% of the heritability on liability scale. For more severe ID it was lower at 0.6%.
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Finally, we identified a homozygote variant in the CRADD gene to be a cause of a specific syndrome with ID and pachygyria. The frequency of this variant is 50x higher in the Finnish population than in non-Finnish Europeans, demonstrating the benefits of utilizing population isolates in rare variant analysis of diseases under negative selection.
Introduction
Intellectual disability (ID) is a relatively common disorder characterized by deficits in both intellectual and adaptive functioning in conceptual, social and practical domains. A diagnosis of ID requires deficits in a broad range of intellectual functions, deficits in adaptive functioning resulting in failure to meet developmental and sociocultural standards for personal independence and social responsibility, and an onset during the developmental period 1 . The population prevalence estimates of ID varies between 1%-3% and is clearly lower (<0.5%) for more severe forms of ID (IQ<50) than for mild forms 2 .
The genetic contribution to severe and moderate intellectual disability has been extensively studied. While genome-wide studies using microarrays and exome sequencing have identified a prominent role of de novo copy number variations (CNVs), INDELs and single nucleotide variants in mostly severe ID with reported diagnostic yields of 13%-42%, their role in mild ID is less studied but expected to have a less prominent role 3, 4 . Intriguingly siblings of mild ID individuals have low IQ compared to the general population whereas the IQ of siblings of severe ID individuals do not differ from the general population 5 . This suggests that mild ID represents a low extreme in a normal distribution of IQ, while severe ID is a distinct condition with different etiology 5 .
The observation that intellectual disability has a high co-morbidity with other neurodevelopmental and neuropsychiatric diseases such as autism, schizophrenia and epilepsy has stimulated the hypothesis that these diseases might, in part, have shared genetic backgrounds and thus alterations in the same pathways 6 .
One strategy to shed light on the genetic background of diseases is to use populations where the incidence of the trait is higher, and/or where the population history provides benefits for variant identification. Finland is a wellcharacterized genetic isolate where the small size of the founder population, subsequent bottleneck effects, and genetic drift have caused an enrichment of some rare and low frequency variants as compared to other European populations 7, 8 . In a population with a recent bottleneck, such as Finland, variants conferring a high risk for a disease with reduced fecundity can exist at markedly higher frequencies than in older populations because negative selection has not had time to drive down the allele frequencies, and therefore these variants are easier to associate to a disease 9 .
Interestingly, ID ( Figure 1 ) and other neurodevelopmental and neuropsychiatric diseases (NDD) like schizophrenia (Supplementary Figure 1) have a higher prevalence in North-Eastern Finland as compared to South-Western Finland 10, 11 .
It has been hypothesized that such a pattern is related to the recent bottlenecks of these regions. The Eastern and Northern parts of Finland were inhabited more permanently only after the internal migration of small groups in the 16th century while Southern coastal regions were already more populous (Figure 1 ) 12 . The regional genetic differences between the early and late settlements (east-west and north-south) can be clearly recapitulated from genome-wide common SNP data 13, 14 .
The aforementioned Finnish population history and the observation of geographical differences in the prevalence of neurodevelopmental diseases in Finland motivated us to initiate the Northern Finland Intellectual Disability (NFID) study, a geographically based cohort of ID patients and their family members recruited from specialty clinics in the two most Northern provinces of Finland.
The only study exclusion criterion was having a known or suspected genetic or environmental cause for the phenotype and therefore the majority of our patients have the most common mild form of ID (259/498). Here we describe a comprehensive genetic characterization of 442 independent NFID patients with unknown disease etiology, enriched for mild (51.4%) forms of ID (Table 1) .
We then examined the genetic architecture of this ID cohort that has undergone a population bottleneck and has a high proportion of mild ID cases. We studied the contribution of rare variants using exome sequencing, common variant polygenic risk scores, and CNVs using genome-wide association study (GWAS) arrays, each for different ID severity categories. We then compared the common and rare variants observed in the ID cohort to a large collection of pre-existing Finnish exome (n=11311) and GWAS array data (n=11699).
We also analyzed the geographical distribution of the polygenic risk variant load of educational attainment, IQ and schizophrenia across different parts of Finland.
Finally, to explore the broader phenotypic impact of identified variant categories and individual variants in the NFID cohort, we compared the identified variants to 640 exome-sequenced individuals with cognitive impairment, schizophrenia (SCZ) or autism spectrum disorder (ASD). Subjects of all ages with either intellectual disability or pervasive and specific developmental disorders (ICD-10 codes F70-79 and F80-89, respectively) of unknown etiology were included. Individuals with copy number variations of unknown clinical significance or highly variable phenotypes were also included in order to uncover other possible factors of genetic etiology. Subjects were identified through hospital records and invited via mail to take part in the study. In addition, they were recruited during routine visits to any of the study centers. All research subjects and/or their legal guardians provided a written informed consent to participate in the study. DNA samples from the participants were extracted primarily from peripheral blood. In a few sporadic cases where a blood sample could not be obtained, DNA was extracted from saliva. 18 . The large regional requirement was set to support analysis across the different DNA chips.
CNV Quality Control
Samples were excluded if they had: 1) a high variance (SD > 0. 
GWAS data processing

Genotyping and Quality Control
All samples were genotyped in seven batches on either the Illumina CoreExome or Illumina PsychArray, which contains 480 000 common variants. The NFID samples were genotyped in three batches, one with Illumina CoreExome and two with PsychArray. FINRISK population controls were genotyped in five batches using Illumina CoreExome.
We excluded markers that exhibited high 'missingness' rates (>5%), low minor allele frequency (<1%), or failed a test of Hardy-Weinberg equilibrium (p< 1e-9).
We also excluded individuals with high rates of heterozygosity (> 3sd from the mean), or a high proportion of missing genotypes (>5% ).
We first split the multiallelic variants in to bi-allelic variant records. Finally, we ensured cases and controls were approximately independent by filtering such that all samples had a pairwise kinship coefficient < 0.0442 to every other sample. We estimated kinship coefficient using King 23 and when possible we always retained cases rather than a related control (N filtered= 1,531).
Variant annotation
We annotated variants using VEP v.85 and the LOFTEE VEP plugin 
Statistical analysis
Identifying likely pathogenic mutations
As a basis for identifying "Likely pathogenic variants" we used a gene list curated within the Deciphering Developmental Disorders study (DDD) and a gene list of 93 exome-wide significant genes from the latest DDD study meta- . These two lists resulted in a total of 818 genes (Supplemental Table 1 ). In the exome of each ID patient we searched for PTV or damaging missense ( , with the distinction that the size criteria for pathogenic CNVs were lowered to 1 Mb for deletions, and 500 kb for de novo deletions. CNVs were additionally considered likely pathogenic (class 1) when overlapping at least 75 % with an established disease associated locus 28 , or deleting an ID associated gene of interest (see above). CNVs were classified as "other high impact variant" (class 2) if both: A) they were never seen in unaffected family members, population controls, or the high quality variant set of the Database of Genomic Variants; and B) they deleted a gene with a high probability of loss-of-function intolerance 25 (pLI>0.95). Otherwise, a CNV was classified as a variant of uncertain significance (class 3).
Polygenic risk scores
As SNP weights we used summary statistics from GWA studies of schizophrenia 29 , IQ 30 , and educational attainment 31 . To avoid potential biases caused by nonrandom regional sampling of individuals in the GWA studies the summary statistics were generated after excluding all Finnish cohorts.
For polygenic scoring we used only well-imputed and genotyped common SNPs (Impute 2 info >= 0.9, allele frequency > 0.05). We pruned the SNPs to a subset of uncorrelated SNPs (r2 < 0.1 within 500kb) and used the remaining SNPs for calculating a polygenic risk score (PRS) for each individual by summing the product of beta from the summary statistics and the number of effect alleles (genotype dosage for imputed SNPs) over all SNPs. Our primary hypothesis testing used a PRS constructed from nominally significant variants (p<0.05) in the original GWAS study. The genetic scores were standardized to z-scores using the mean and standard deviation from Finnish population controls.
For visualizing geographical differences in the PRSs within Finland, we subset the controls to those whose parents' birthplaces were within 100 km of each
other. An individual's coordinates were set to the average of the parents' birthplaces' longitude and latitude. We smoothed the PRS across a map of Finland. At each map position we calculated weighted average by weighting each individual's PRS by the inverse of the squared distance between the map point and the individual's coordinate. Individuals within 50km from the map point contributed equally to the map point, i.e., the full weight was given to those individuals independent of their exact distance from the map point.
Association analysis
To control for population stratification we matched each case to its five genetically closest control individuals given by the first two PC's using the optmatch R package. We wanted to compare the variance explained not only for the whole ID cohort but also in mild and severe ID separately. As mild and severe ID have different population prevalence we transformed the observed scale variance explained to the liability scale 36 . We used the population prevalence from a cumulative normal distribution function with mean 100 and standard deviation 15.
Prevalence of 1.94%, 1.91% and 0.034% were used for all ID (IQ<70), mild ID (50<=IQ<70) and other more severe ID combined (IQ<50) respectively.
Results
We first estimated the regional prevalence of ID in Finland using the social security disability benefits register. We observed a higher prevalence of individuals receiving disability benefits for ID in the Eastern and Northern parts of We then aimed to genetically characterize the NFID patient cohort by exome sequencing and GWAS array genotyping. After joint genotype calling and quality control we analyzed the exomes of 442 independent ID patients ( Figure 2 ). 
Burden of variants in genes not previously implicated in cognitive impairment
Given that ~85% of our cases did not have a variant affecting a known neurodevelopmental disorder gene, we next wanted to assess if there was a burden of rare variants outside of those known genes. We performed an enrichment analysis of variants that were either PTV or constrained damaging missense (MPC>2) variants and not observed in the non-Finnish GnomAD samples or in our internal Finnish controls (separate control cohorts were used for filtering and enrichment, see Table 2 ). First we wanted to verify that there was were not statistically significant due to low counts (OR 2.51, 95% CI: 0.40-11.78, p: 1.8e-1; Figure 3 ).
Figure 3 Enrichment of rare variants in genes not previously associated with NDDs (not observed in GnomAD or Finnish controls) in cases compared to genetically matched controls (see Materials and Methods). Rate in each variant category is first estimated for all novel genes and then after subsetting to only novel high pLI genes. All missense variants are predicted to be deleterious (MPC>2, see methods). On the left the number of carriers and total individuals are given and in parenthesis the proportion of carriers. Circles indicate the odds ratio (OR) and lines indicate the 95% confidence interval of the OR. The synonymous variant identification comparison was performed to
assess if possible differences in the variant identification rate due to batches/capture differences were adequately controlled. PTV= protein truncating variant; CADD = Combined AnnotationDependent Depletion pathogenicity score; pLI = probability of loss of function intolerance.
Copy Number Variants
After filtering CNVs according to our QC protocol (see Methods), we assessed patients (3.7 %) vs. two population controls (0.02 %); Fig 4A) .
Using our classification algorithm, we identified a likely pathogenic CNV in a total of 25 cases, and a further 13 cases were found with a CNV classified as a "high impact variant" (Supplementary Table 3 and seven controls (0.6%) (Fig 4B) . A total of 11 cases (3.8 %) carried a CNV overlapping a region previously linked to syndromic ID, while the same was true for two controls (0.2%) (Figure 4 A) . The syndromic CNVs identified in controls were non-ID associated (12p13.33 deletion) and a region with known variable phenotype (22q11 duplication syndrome 39 ). Previously known ID-associated gene was deleted in 13 cases (3.0%) but in none of the controls. Figure 5) , totaling to 38 cases with a potential CNV deletion associated with ID. 
Total genetic diagnosis rate
After combining exome and CNV data, we identified a likely diagnosis for 85 
Polygenic common variant load
As it is evident that exome sequencing and CNV analysis identified a likely cause for ID in only 19.6% of the cases, we wanted to study the contribution of the polygenic load of common variants associated to intelligence quotient (IQ), educational attainment (EDU) and schizophrenia (SCZ) to Northern Finnish ID.
There is a partial common variant genetic overlap between cognitive function and Figure 1) .
First, to create a proper reference for NFID cases, we analyzed whether the geographical distribution of PRSs correspond to the population history of Finland.
We mild, moderate and profound. The PRS for EDU was lower and for SCZ higher in the mild ID cases compared to more severe forms, but the differences were not statistically significant (Supplementary Figure 3) . Unexpectedly, the IQ PRS in the mild ID group was not significantly different from matched population controls. However the most severe ID form differed significantly from the population controls (Supplementary Figure 3) . We also hypothesized that the EDU and IQ PRSs would be lower and SCZ PRS would be higher in those patients for which a likely causative mutation was not identified. Thus, we compared the PRSs between cases in different diagnostic categories but did not observe statistically significant differences between groups (Supplementary Figure 4) . Assuming we had sufficient power to detect differences, this suggests that in addition to high penetrance variants, a more general polygenic component also contributes to the genetic background of ID.
Variants enriched in Finland
Finally, we asked if some variants enriched in Finland might contribute to the Northern Finnish ID phenotype as variants with reduced reproductive fitness can exist in markedly higher frequency in a population with a recent bottleneck 9 .
We aimed to identify a subset of variants that are rare elsewhere but significantly more common in Finland using the largest exome variant database to date (GnomAD/ExAC v 2). We hypothesized that some of these variants would be associated with ID in the NFID cohort. To identify these variants, we compared the allele frequencies in Finnish samples to the allele frequency in non-Finnish
Europeans. Loss-of-function and missense variants in the range of 0.1% -5%
(Supplementary Figure 9) were proportionally more enriched compared to other variants, suggesting that damaging variants that survived through the bottleneck are elevated in frequency. This is in line with our previous observation in smaller datasets 8 .
Dominant variants enriched in Finland
We first analyzed low frequency and rare (MAF < 0.1% in GnomAD non-Finnish population maximum) single missense and loss-of-function variants enriched at least two-fold in Finland or absent in GnomAD non-Finnish individuals.
Singletons were excluded from the analysis (13,483 variants; 12,628 missense, 855 PTV). We identified 396 variants nominally (p<0.05) associated with ID (Supplementary Table 4 ). We then aimed to gain confidence or refute the identified associations by analyzing NDD cases and genetically matched controls from the Northern and Southern Finland (Table 2) . After meta-analyzing all three cohorts, we identified 29 variants associated with a p-value < 0.001 (20 variants were found in cases only across the three cohorts). However, none of the metaanalyzed variants surpassed a multiple-testing correction for 13,483 tests.
Recessive variants enriched in Finland
Consistent with the bottleneck effect and the associated Finnish Disease
Heritage, we expected to observe enrichment in recessive acting variants. We therefore asked if some of the enriched PTV or missense variants with low allele frequency in GnomAD (AF <0.01) were recessively associated with ID. We excluded singleton homozygotes (across all cases and controls) and variants observed as homozygous in GnomAD. After these filtering steps we performed a recessive analysis for 1408 variants (1379 missense variants and 29 PTVs).
Eighteen variants were observed as homozygous more than once in cases across the three cohorts but not in controls (Table 3) .
In the recessive analysis we identified a homozygous missense variant in the 
Variance explained by different variant categories
To put the relative contribution of different classes of genetic variation to a context, we estimated the variance explained by each category that was significant in the case-control comparisons. We added the 3 CRADD homozygotes to the likely pathogenic category as we clearly demonstrated the variant to be a causative recessive variant (see Table 4 ). For likely diagnostic and other high impact variants we used genetically matched cases and controls for which both exome and CNV data was available (433 cases and 1,100 controls). For the polygenic risk score we used 439 cases and 2,195 genetically matched controls. As we observed geographical differences in PRSs within
Finland, we corrected the variance explained estimation using the first four PCs.
All the PRSs were significantly associated with ID. The PRS's contribution to heritability on the liability scale is lower (IQ 0.48%, 95% CI: 0.067%-1.25%; SCZ 0.55%, 95% CI: 0.078-1.5%; EDU 0.94%, 95% CI: 0.31%-1.92%) than variance explained by likely pathogenic variants in known genes (4.54%, 95% CI: 3.04%-6.15%) or other high impact variants (in constrained genes not yet linked to ID 2.25%, 95% CI: 1.30%-3.52%) ( Figure 7A) . When comparing the different ID severities, the heritability explained on liability scale was the highest in mild ID for EDU (2.17%, 95% CI: 0.60%-4.77%) whereas it was smaller in more severe ID (0.55%, 95% CI: 0.04%-1.60%). The heritability estimation for all PRSs and ID categories is presented in Supplementary Figure 10 .
The variance explained by likely pathogenic variants in known genes explained a slightly higher proportion of variance on the liability scale in more severe ID (7.01%, 95% CI: 4.49%-9.92%) than in mild ID (4.25%, 95% CI: 2.6%-9.5%).
This is expected as we observed a significantly lower proportion of likely pathogenic variants in mild ID (13.7%) vs. more severe ID (27.2%) (Figure 7 B) . The PRS for IQ was only slightly below the matched controls in mild ID. This was unexpected. The reason remains speculative, but could potentially be contributed by the fact that the IQ PRS was generated from a smaller study samples (n=78,308) than the EDU score (n=293,723).
After observing a significant association between the common variant load and ID we hypothesized that PRSs would be different in those individuals in whom a likely pathogenic variant was identified and those where such variants were not identified. However such a difference was not observed, not even a suggestive trend (Supplementary Figure 4) . This observation could be explained by assuming that rare high-risk variants and the common variant load act additively to increase the risk of ID. Another explanation could be that there still might be other unidentified strong or moderate variants explaining the phenotype in many of the cases in which we were not able to conclusively identify a causative variant. We explored this hypothesis by grouping patients into the "Other high impact variant" category if they carried a PTV, CNV or damaging missense mutation in loss of function intolerant genes not previously linked to NDDs, but did not observe a difference in PRSs in that group either (Supplementary Figure   4 ). An additive effect of high impact rare variants and common variant polygenic load has recently been suggested in the genetic etiology of ASD 49 , our data suggests a similar genetic architecture for ID.
Finally, we studied if some variants enriched in Finland in the relatively recent bottleneck would be associated with ID in our cohort. We conclusively identified a recessive variant in the CRADD gene enriched in Finland in three NFID patients and one NDD patient from the population NDD cohorts ( Figure 10) . ID or autism were not systematically diagnosed in the collection. Further studies are needed to conclusively determine if some of the other identified candidate genes are truly ID associated.
In conclusion, we demonstrate that a common variant polygenic load is a contributing factor in ID and more broadly characterized the genetic architecture of mild ID, which so far has been understudied. We also show that some The datasets generated during and/or analysed during the current study are not publicly available due to patient confidentiality and multiple different consents of population cohorts used but subset of the data are available from the corresponding author on reasonable request.
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